Endothelium and atherogenesis: endothelial therapy revisited

Area of Science:

• Vascular Biology
• Cardiovascular Disease
• Endothelial Function

Background:

• Atherosclerosis is a chronic inflammatory vascular disease causing significant cardiovascular morbidity and mortality.
• Endothelial dysfunction, characterized by reduced nitric oxide (NO) bioavailability and increased oxidative stress, is central to atherosclerosis progression.
• Impaired endothelial function contributes to leukocyte adhesion, thrombosis, inflammation, and vascular tone increase.

Purpose of the Study:

• To discuss mechanisms underlying endothelial dysfunction in atherosclerosis.
• To review therapeutic strategies aimed at improving endothelial pathways in atherosclerosis.
• To evaluate the potential of interventions to restore NO bioactivity and enhance vascular function.

Main Methods:

• Review of mechanisms contributing to endothelial dysfunction in atherosclerosis.
• Discussion of therapeutic approaches targeting the renin-angiotensin system, endothelin system, and statin therapy.
• Analysis of studies demonstrating improved vascular function in experimental models.

Main Results:

• Decreased NO bioavailability and increased endothelin-1 production are key contributors to atherosclerosis.
• Inhibition of the renin-angiotensin and endothelin systems, along with statin therapy, restores endothelium-dependent NO bioactivity.
• These interventions improve vascular function in experimental hypercholesterolemia, hypertension, and heart failure.

Conclusions:

• Restoring NO bioactivity is a promising therapeutic strategy for atherosclerosis.
• Targeting endothelial pathways can mitigate vascular and myocardial complications.
• Therapeutic interventions discussed hold potential for patients at risk or with established atherosclerosis.